ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995

$25 Million In Federal Aid to Jackson Laboratory approved By Senate; NIH, Natcher Are Opposed

August 11, 1989

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

March 28, 2008

In Brief: Lasker awards Recognizes Six Scientists; NCAB Honors Vande Woude for Work At NCI

October 1, 1999

House Passes Cancer Act Renewal With Provision Permitting NCI To Reinstate Training Program

May 10, 1974